144 related articles for article (PubMed ID: 17912536)
1. Health economic evaluation of ferucarbotran-enhanced MRI in the diagnosis of liver metastases in colorectal cancer patients.
Annemans L; Lencioni R; Warie H; Bartolozzi C; Ciceri M; Müller U
Int J Colorectal Dis; 2008 Jan; 23(1):77-83. PubMed ID: 17912536
[TBL] [Abstract][Full Text] [Related]
2. Health economic evaluation of liver MRI in colorectal cancer patients.
Helmberger T; Annemans L; Warie H; Müller U
Eur Radiol; 2004 Jan; 14 Suppl 1():C13. PubMed ID: 15113063
[No Abstract] [Full Text] [Related]
3. Health-economic evaluation of three imaging strategies in patients with suspected colorectal liver metastases: Gd-EOB-DTPA-enhanced MRI vs. extracellular contrast media-enhanced MRI and 3-phase MDCT in Germany, Italy and Sweden.
Zech CJ; Grazioli L; Jonas E; Ekman M; Niebecker R; Gschwend S; Breuer J; Jönsson L; Kienbaum S
Eur Radiol; 2009 Jun; 19 Suppl 3():S753-63. PubMed ID: 19484243
[TBL] [Abstract][Full Text] [Related]
4. Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients.
Kim HJ; Kim KW; Byun JH; Won HJ; Shin YM; Kim PN; Lee MS; Lee MG
AJR Am J Roentgenol; 2006 Apr; 186(4):1059-66. PubMed ID: 16554579
[TBL] [Abstract][Full Text] [Related]
5. Clinical management of hepatic malignancies: ferucarbotran-enhanced magnetic resonance imaging versus contrast-enhanced spiral computed tomography.
Lencioni R; Della Pina C; Bruix J; Majno P; Grazioli L; Morana G; Filippone A; Laghi A; Bartolozzi C
Dig Dis Sci; 2005 Mar; 50(3):533-7. PubMed ID: 15810637
[TBL] [Abstract][Full Text] [Related]
6. [Obsolete methods in examination of the liver with MRI].
Schadmand-Fischer S
Rofo; 1998 Dec; 169(6):679-80. PubMed ID: 9930229
[No Abstract] [Full Text] [Related]
7. Ferumoxide-enhanced magnetic resonance imaging techniques in pre-operative assessment for colorectal liver metastases.
van Etten B; van der Sijp J; Kruyt R; Oudkerk M; van der Holt B; Wiggers T
Eur J Surg Oncol; 2002 Sep; 28(6):645-51. PubMed ID: 12359202
[TBL] [Abstract][Full Text] [Related]
8. Cost evaluation of gadoxetic acid-enhanced magnetic resonance imaging in the diagnosis of colorectal-cancer metastasis in the liver: Results from the VALUE Trial.
Zech CJ; Justo N; Lang A; Ba-Ssalamah A; Kim MJ; Rinde H; Jonas E
Eur Radiol; 2016 Nov; 26(11):4121-4130. PubMed ID: 26905871
[TBL] [Abstract][Full Text] [Related]
9. Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US.
Vogl TJ; Schwarz W; Blume S; Pietsch M; Shamsi K; Franz M; Lobeck H; Balzer T; del Tredici K; Neuhaus P; Felix R; Hammerstingl RM
Eur Radiol; 2003 Feb; 13(2):262-72. PubMed ID: 12598989
[TBL] [Abstract][Full Text] [Related]
10. Small malignant hepatic tumor detection in gadolinium- and ferucarbotran-enhanced magnetic resonance imaging: does combining ferucarbotran-enhanced T2*-weighted gradient echo and T2-weighted turbo spin echo images have additive efficacy?
Kim YK; Lee YH; Kwak HS; Kim CS; Han YM
Korean J Radiol; 2008; 9(6):510-9. PubMed ID: 19039267
[TBL] [Abstract][Full Text] [Related]
11. Detection of colorectal liver metastases: prospective comparison of unenhanced and ferumoxides-enhanced magnetic resonance imaging at 1.5 T, dual-phase spiral CT, and spiral CT during arterial portography.
Lencioni R; Donati F; Cioni D; Paolicchi A; Cicorelli A; Bartolozzi C
MAGMA; 1998 Dec; 7(2):76-87. PubMed ID: 9951768
[TBL] [Abstract][Full Text] [Related]
12. Characterization of liver metastases: the efficacy of biphasic magnetic resonance imaging with ferucarbotran-enhancement.
Hong HS; Byun JH; Won HJ; Kim KW; Lee SS; Lee MG; Yun SC
Clin Radiol; 2010 Sep; 65(9):701-7. PubMed ID: 20696297
[TBL] [Abstract][Full Text] [Related]
13. Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.
Kim SH; Choi D; Kim SH; Lim JH; Lee WJ; Kim MJ; Lim HK; Lee SJ
AJR Am J Roentgenol; 2005 Apr; 184(4):1069-76. PubMed ID: 15788575
[TBL] [Abstract][Full Text] [Related]
14. Ferumoxide-enhanced MRI in patients with colorectal cancer and rising CEA: surgical correlation in early recurrence.
Said B; McCart JA; Libutti SK; Choyke PL
Magn Reson Imaging; 2000 Apr; 18(3):305-9. PubMed ID: 10745140
[TBL] [Abstract][Full Text] [Related]
15. Imaging of small hepatic metastases of colorectal carcinoma: how to use superparamagnetic iron oxide-enhanced magnetic resonance imaging in the multidetector-row computed tomography age?
Motosugi U; Ichikawa T; Nakajima H; Sou H; Sano M; Sano K; Araki T; Iino H; Fujii H; Nakazawa T
J Comput Assist Tomogr; 2009; 33(2):266-72. PubMed ID: 19346857
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of colorectal hepatic metastases: Contrast-enhanced ultrasonography versus contrast-enhanced computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging with diffusion-weighted imaging.
Muhi A; Ichikawa T; Motosugi U; Sou H; Nakajima H; Sano K; Kitamura T; Faima Z; Fukushima K; Araki T; Iino H; Mori Y; Fujii H
J Magn Reson Imaging; 2010 Nov; 32(5):1132-40. PubMed ID: 21031519
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of Resovist-enhanced MRI: results of an Italian multicenter trial.
Lencioni R; Bartolozzi C;
Eur Radiol; 2004 Jan; 14 Suppl 1():C10. PubMed ID: 15113061
[No Abstract] [Full Text] [Related]
18. Usefulness of combining sequentially acquired gadobenate dimeglumine-enhanced magnetic resonance imaging and resovist-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: comparison with computed tomography hepatic arteriography and computed tomography arterioportography using 16-slice multidetector computed tomography.
Kim YK; Kwak HS; Han YM; Kim CS
J Comput Assist Tomogr; 2007; 31(5):702-11. PubMed ID: 17895780
[TBL] [Abstract][Full Text] [Related]
19. [Differential diagnosis of focal liver lesions using contrast-enhanced MRI with SHU 555 A in comparison with unenhanced MRI and multidetector spiral-CT].
Jung G; Poll L; Cohnen M; Saleh A; Vogler H; Wettstein M; Willers R; Mödder U; Koch JA
Rofo; 2005 Nov; 177(11):1571-7. PubMed ID: 16302139
[TBL] [Abstract][Full Text] [Related]
20. Detection of liver metastases: Gadoxetic acid-enhanced three-dimensional MR imaging versus ferucarbotran-enhanced MR imaging.
Kim YK; Lee YH; Kwak HS; Kim CS; Han YM
Eur J Radiol; 2010 Jan; 73(1):131-6. PubMed ID: 18996659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]